Tango Therapeutics, Inc.
$21.75
Market Cap
$3.96B
Shares Outstanding
168.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Aug 11, 2021
Round Lot
100
Locale
US
Day Open
$23.33
Day High
$23.55
Day Low
$21.72
Volume
6.24M
VWAP
$21.92
Prev Close
$23.49
Transactions
--
Acc. Volume
--
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
Tango Therapeutics, Inc. (TNGX) closed the 2026-09-18 session at $21.75, down 7.41% versus the previous close (-1.74). The stock opened at $23.33 and traded between $21.72 and $23.55 during that session. Session trading volume was 6.2M shares. The volume-weighted average price (VWAP) is $21.92.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
Tango Therapeutics, Inc. has a market capitalization of $3.96 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. TNGX is listed on the XNAS exchange. The company employs approximately 137 people. Tango Therapeutics, Inc. is headquartered in BOSTON, MA. The recorded listing date is 2021-08-11.
On this page you can find market TNGX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.